Bill of Health

APRIL 21, 2023

FDA lawsuit and its potential implications for pharmaceutical regulation, and an estimate of U.S. public investment in the development of mRNA COVID-19 vaccines. Eroding Judicial Deference to the FDA – Consequences for Public Health. Brown BL, Kesselheim AS, Sarpatwari A. N Engl J Med. Epub ahead of print.

COVID-19 Vaccine 147

COVID-19 Vaccine FDA COVID-19 Public Health 147

Bill of Health

APRIL 7, 2023

By Aparajita Lath Two articles published last month in the BMJ analyze the public investment and financing of mRNA COVID-19 vaccines, highlighting the extensive government funding that has supported the development of mRNA technology from 1985 to 2022. government substantially de-risking the vaccine development process.

COVID-19 Vaccine 147

COVID-19 Vaccine COVID-19 Governance Public Health 147

Drug & Device Law

FEBRUARY 8, 2024

29, 2024), would have been pending if filed sooner was opened back in 2012. In Hinton , the plaintiff’s sling was implanted in August 2019, after pretty much all the relevant FDA actions on pelvic mesh devices. The More Things Change Pelvic mesh litigation has been going on for more than a decade. The MDL in which Hinton v. Boston Sci.

COVID-19 Vaccine 52

COVID-19 Vaccine COVID-19 FDA Public Health 52

Drug & Device Law

JANUARY 4, 2024

2012), we hailed it as the best decision of 2012. So we do have comments on the bizarre complaint that the Texas attorney general recently filed over COVID-19. The complaint, brought under the Texas consumer protection statute, sued a major manufacturer of COVID-19 vaccine that was used to control the recent pandemic.

COVID-19 Vaccine 59

COVID-19 Vaccine COVID-19 FDA Public Health 59